### ğŸ«  Arrhythmia: Torsades de Pointes

#### âœ… True Statements
1. **Torsades de pointes** is a type of **polymorphic ventricular tachycardia** associated with **QT interval prolongation**.
2. **Torsades de pointes** is characterized by an **undulating QRS pattern** that appears to twist around the baseline on electrocardiogram (ECG).
3. **Torsades de pointes** may be initiated by a **premature ventricular complex (PVC)** occurring during the **repolarization phase** of the preceding beat (an **"R-on-T" event**).
4. **Macrolide and quinolone antibiotics** may prolong the **QT interval**, particularly when used with other **QT-prolonging medications** such as certain **antidepressants** and **antipsychotics**.
5. Patients with a **history of long QT interval** or those taking **QT-prolonging medications** are at increased risk for **torsades de pointes**.

#### ğŸ’¬ Extra
1. **Torsades de pointes** is most often acquired and not congenital; drug effects and electrolyte abnormalities are frequent causes.
3. The **"R-on-T" phenomenon** represents a vulnerable period where ectopy may trigger arrhythmia due to prolonged repolarization.
4. **Macrolides** (e.g., erythromycin, azithromycin) and **fluoroquinolones** (e.g., levofloxacin) are among the most common QT-prolonging antibiotics.

#### ğŸ”· Tags
#Cardiology #Arrhythmia #HospitalCare #EmergentCare #QTProlongation #TorsadesDePointes #VentricularTachycardia

#### ğŸ“™ Reference
MKSAP 19, Cardiovascular Medicine. American College of Physicians.

#### ğŸ†” Question ID
CVVDX24023

#### ğŸ•’ Last Updated
January 2025

---

#### ğŸ“– Related Text
MKSAP 19: Cardiovascular Medicine â€” Arrhythmias, Ventricular Arrhythmias, Polymorphic Ventricular Tachycardia

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Torsades de pointes** is a form of **polymorphic ventricular tachycardia (VT)** typically caused by **pathologic prolongation of the QT interval**.
2. **Torsades de pointes** is typically triggered by a **ventricular ectopic beat (PVC)** during the **prolonged repolarization period**, described as the **"R-on-T" phenomenon**.
3. **QT prolongation** is frequently **acquired** due to **medications**, **cardiac ischemia**, or **electrolyte abnormalities**.
4. Less commonly, **QT prolongation** may be due to an **underlying genetic defect**.
5. Acute treatment of **torsades de pointes** includes **defibrillation** and **intravenous magnesium**.
6. Refractory or recurrent **torsades de pointes** may require **sympathomimetic agents** (e.g., **isoproterenol**) or **temporary pacing**.
7. Chronic management of **torsades de pointes** includes **removal of offending drugs**, **electrolyte correction**, and/or **revascularization**.
8. **Chronic Î²-blocker therapy** may be used in patients with **inherited long QT syndrome** to reduce risk of torsades de pointes.

#### ğŸ’¬ Extra
1. This type of ventricular tachycardia presents with beat-to-beat variation in QRS morphology and axis, creating a "twisting" appearance.
3. Common culprits include **antidepressants**, **antibiotics** (macrolides, fluoroquinolones), **antiarrhythmics**, and certain **antipsychotics**.
5. **Magnesium sulfate** stabilizes cardiac membranes and suppresses early afterdepolarizations even if magnesium level is normal.
6. **Isoproterenol** or pacing increases heart rate, shortening the QT interval and reducing risk of further ectopy.
7. Identifying and addressing underlying causes is crucial for preventing recurrence.
8. **Î²-Blockers**, especially **nadolol** or **propranolol**, are first-line agents in congenital long QT syndromes.

#### ğŸ”· Tags
#TorsadesDePointes #PolymorphicVT #QTProlongation #PVC #Magnesium #Isoproterenol #BetaBlocker #InheritedArrhythmia #EmergencyCardiology

---

#### ğŸ–¼ï¸ Supplemental Figures

<figure>
  <img src="ECG Showing Torsades de Pointes.jpg" alt="ECG Showing Torsades de Pointes">
  <figcaption>
    ECG showing torsades de pointes, also known as polymorphic ventricular tachycardia.
  </figcaption>
</figure>
